153 related articles for article (PubMed ID: 7229726)
1. New horizons for therapeutic nuclear medicine in 1981.
Beierwaltes WH
J Nucl Med; 1981 Jun; 22(6):549-54. PubMed ID: 7229726
[TBL] [Abstract][Full Text] [Related]
2. Horizons in radionuclide therapy: 1985 update.
Beierwaltes WH
J Nucl Med; 1985 Apr; 26(4):421-7. PubMed ID: 3884750
[TBL] [Abstract][Full Text] [Related]
3. [Remission incidence and adverse effects in low-dosage radioactive phosphorus therapy of polycythemia vera].
Hauswaldt C; Horejschi J; Emrich D; Heckner F; Douwes FW; Ziesemer G
Verh Dtsch Ges Inn Med; 1975; 81():1128-30. PubMed ID: 1229414
[No Abstract] [Full Text] [Related]
4. [Radiophosphorus therapy of polycythemia vera].
Hör G; Pabst HW
Ther Umsch; 1973 Nov; 30(11):789-96. PubMed ID: 4591693
[No Abstract] [Full Text] [Related]
5. [Nuclear medicine--therapeutic advances into new dimensions?].
Hahn K
Rofo; 2000 Mar; 172(3):207-9. PubMed ID: 10778449
[No Abstract] [Full Text] [Related]
6. Observations on polycythemia vera turning into acute or chronic granulocytic leukemia during treatment with radioactive phosphorus 32P.
Krańik W
Pol Med Sci Hist Bull (1973); 1975; 15(4):447-52. PubMed ID: 1063385
[TBL] [Abstract][Full Text] [Related]
7. Radiation dose to the upper spine from therapeutic administrations of iodine-131-sodium iodide.
Stabin MG
J Nucl Med; 1993 Apr; 34(4):695-6. PubMed ID: 8455090
[TBL] [Abstract][Full Text] [Related]
8. [Transition of polycythemia vera into acute or chronic granulocytic leukemia in the course of treatment with radioactive P-32].
Kraśnik W
Pol Tyg Lek; 1975 Feb; 30(6):233-6. PubMed ID: 1054155
[No Abstract] [Full Text] [Related]
9. The use of 32 phosphorus (32P) in the treatment of polycythemia vera.
Parmentier C; Gardet P
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):189-92. PubMed ID: 8036140
[TBL] [Abstract][Full Text] [Related]
10. Treatment with radiopharmaceutical drugs.
McDougall IR
Ration Drug Ther; 1978 Jan; 12(1):1-7. PubMed ID: 628766
[No Abstract] [Full Text] [Related]
11. [Treatment with radioisotopes].
McDougall IR
Internist (Berl); 1978 Jul; 19(7):431-6. PubMed ID: 357330
[No Abstract] [Full Text] [Related]
12. [Therapeutic roles of nuclear medicine].
Bisson G; Chartrand R
Union Med Can; 1990; 119(4):175-7. PubMed ID: 2201115
[No Abstract] [Full Text] [Related]
13. [Acute leukemia and primary Vaquez' polycythemia. 20 cases].
Bernard JF; Renoux M; Dhermy D; Schneider M; Chouraqui F; Amar M; Boivin P
Sem Hop; 1978 Sep 18-25; 54(25-28):797-804. PubMed ID: 214857
[TBL] [Abstract][Full Text] [Related]
14. [Cancers caused by therapeutic noxae: cancer and radiotherapy].
Tubiana M
Bull Cancer; 1983; 70(1):47-54. PubMed ID: 6839034
[TBL] [Abstract][Full Text] [Related]
15. [Low risk of cancer after treatment of hyperthyroidism with iodine-131].
Holm LE; Hall P; Lundell G; Berg G; Bjelkengren G; Ericsson UB; Tennvall J; Hallquist A; Lidberg M; Wiklund K
Lakartidningen; 1992 Sep; 89(38):3043-6. PubMed ID: 1369747
[No Abstract] [Full Text] [Related]
16. [Radionuclide therapy of malignant tumors].
Altenbrunn HJ
Z Gesamte Inn Med; 1978 Jul; 33(14):475-84. PubMed ID: 581247
[TBL] [Abstract][Full Text] [Related]
17. The role of radioiodine treatment in childhood hyperthyroidism.
Becker DV
J Nucl Med; 1979 Aug; 20(8):890-4. PubMed ID: 396368
[No Abstract] [Full Text] [Related]
18. Radiotherapy of carcinoma of the thyroid.
Howard N; Smithers DW
Monogr Neoplast Dis Var Sites; 1970; 6():259-68. PubMed ID: 5527677
[No Abstract] [Full Text] [Related]
19. Iodine-131 in breast milk following therapy for thyroid carcinoma.
Robinson PS; Barker P; Campbell A; Henson P; Surveyor I; Young PR
J Nucl Med; 1994 Nov; 35(11):1797-801. PubMed ID: 7965159
[TBL] [Abstract][Full Text] [Related]
20. Contributions of nuclear medicine to the therapy of malignant tumors.
Feinendegen LE
Strahlenther Onkol; 1991 Nov; 167(11):619-27. PubMed ID: 1962275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
